The 13-valent pneumonia vaccine does not protect against the virus, but against each serotype of Streptococcus pneumoniae. The 13-valent pneumococcal vaccine is used for active immunization of infants and young children against invasive diseases, such as bacteremic pneumonia and meningitis, sepsis and bacteremia, due to Streptococcus pneumoniae serotypes 1, 3, 4, 5, and 6A, as well as 6B, 7F, 9V, 14, and 18C, and also 19A, 19F, and 23F. The Streptococcus pneumoniae serotype contained in the 13-valent pneumonia vaccine is prophylactic and protective, and should not be used to prevent invasive diseases, pneumonia, or otitis media caused by serotypes other than the 13-valent pneumonia vaccine, as well as by other microorganisms. The common adverse effects of 13-valent pneumonia vaccine are redness, swelling, and hot pain at the vaccination site, as well as generalized fever. There are certain contraindications to the administration of the 13-valent pneumonia vaccine, and it is recommended to consult a specialist before vaccination.